Explore the innovative concept of vibe coding and how it transforms drug discovery through natural language programming.

Explore the impact of AI in drug discovery as 2026 promises critical clinical results and industry transformations.

Rochester, Minn.-based Mayo Clinic and pharmaceutical giant Merck are teaming up to leverage AI for drug discovery and ...

Artificial intelligence (AI) can accelerate drug development, reduce costs, and improve treatment efficacy, but faces challenges like data quality and regulatory hurdles. Over 900 FDA-approved ...

We are glad that Isomorphic is helping advance the field and are able to match the level of performance we demonstrated at the ARDD conference in Copenhagen last August. In August, Deep Origin ...

Google Research and Google DeepMind recently released a paper announcing the creation of a new LLM for drug discovery and therapeutic development dubbed Tx-LLM, fine-tuned from PaLM-2. Tx-LLM utilizes ...

Generative AI based on Large Language Models (LLMs), the technology behind popular tools like ChatGPT and Google Gemini, is revolutionizing various industries, including the world of drug discovery.

After sharing word that it would be prioritizing artificial intelligence to aid discovery work, Takeda Pharmaceuticals has inked a multiyear deal to access Iambic Therapeutics' broad suite of& | ...

Healx, a U.K. startup using AI to discover new drugs for rare diseases, has raised $47 million in a Series C round of funding co-led by Europe’s Atomico and Silicon Valley-based R42. The company also ...